William Go, M.D., Ph.D., oversees all aspects of A2 Bio’s development of T cell therapies utilizing the company’s novel platform technology.Previously, Will worked at Kite Pharma (acquired by Gilead) where he developed novel immune-cellular therapies for the treatment of cancer...
Read More →